CRS is an immunotherapy-induced systemic inflammatory syndrome that occurs due to the hyperactivation of the immune system that results in the release of multiple cytokines, including TNFα, IL6, IL10, and IFN. This evidence concerns the gene IFNA1 and congenital rubella syndrome.